Condition

Colon Neoplasms

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common interventions7

Lead sponsors shown3

Clinical trials

3 shown

Feasibility Study of the SEGER Device in Laparoscopic Gastrointestinal SurgeryNCT07508592 · 2026-02-17

COMPLETED

CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceNCT02900248 · 2017-10-02

TERMINATED

A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)NCT00600496 · 2007-12-14

COMPLETED

Common interventions

AZD6244DRUG1 DacarbazineDRUG1 DocetaxelDRUG1 ErlotinibDRUG1 Provider determinedOTHER1 SEGER DeviceDEVICE1 TemsirolimusDRUG1

Leading sponsors

AstraZeneca 1 CureOne 1 Seger Surgical Solutions 1

Trial status mix

COMPLETED2

TERMINATED1

Phase mix

NA1

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.